Compugen (CGEN) Research Hub

Compugen (CGEN) trades on NASDAQ, IL in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.88 USD (-3.09%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 6.60, market cap 0.23B. This hub links to the full technical, earnings and options research available for CGEN.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, IL
Last close1.88 USD (-3.09%)
52-week range1.87 USD – 2.94 USD
Trend regimeRange
14-day RSI31.5 (Bearish)
Trailing P/E6.60
Market cap0.23B
Dividend yield0.00%
Next earnings2026-08-03

Available research for CGEN

Earnings

CGEN earnings date and last-quarter result: next report 2026-08-03, last quarter miss, P/E 6.60. Updated 2026-07-23.

Options: Covered Call

Covered Call on CGEN: how it works, illustrative setup around the real 1.88 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on CGEN: how it works, illustrative setup around the real 1.88 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on CGEN: how it works, illustrative setup around the real 1.88 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

CGEN technical analysis: range, last 1.88 USD, RSI 31.5, 52w range 1.87 USD–2.94 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is CGEN in?

Compugen (CGEN) is classified under Healthcare (Biotechnology), listed on NASDAQ, IL.

Is CGEN in an uptrend or downtrend?

As of 2026-10-26, CGEN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is CGEN's trailing P/E ratio?

CGEN's trailing P/E is 6.60, with a market cap of 0.23B. See the earnings research page for full valuation detail.

When does CGEN next report earnings?

CGEN is next scheduled to report earnings on 2026-08-03.